PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsarteriosclerosis
MeSH D001161 - arteriosclerosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001157:Arterial occlusive diseases
1 Company
1 Drug
$
Success rate
D001161: 
Arteriosclerosis
5 Companies
1 Drug
$
Success rate
D001162:Arteriosclerosis obliterans
1 Company
1 Drug
$
Success rate
D002537:Intracranial arteriosclerosis
0 Companies
0 Drugs
Success rate
D003324:Coronary artery disease
105 Companies
29 Drugs
$
Success rate
D050197:Atherosclerosis
5 Companies
4 Drugs
$
Success rate
D050379:Arteriolosclerosis
0 Companies
0 Drugs
Success rate
D000094667:Penetrating atherosclerotic ulcer
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
40%
2/5
Phase 3
75%
3/4
Approved: 1Overall Success rate: 30%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Actelion
Epoprostenol
GSK
Epoprostenol
Mylan
Epoprostenol
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use